EDGAR Filing Documents for 0001193125-22-104314

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-22-104314

Filing Date

2022-04-13

Accepted

2022-04-13 16:20:29

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	d342209ddefa14a.htm	DEFA14A	28272
2	GRAPHIC	g342209g04h00.jpg	GRAPHIC	40943
3	GRAPHIC	g342209pc001.jpg	GRAPHIC	1298
4	GRAPHIC	g342209pc001a.jpg	GRAPHIC	1276
5	GRAPHIC	g342209pc001b.jpg	GRAPHIC	883
6	GRAPHIC	g342209pc001c.jpg	GRAPHIC	881
7	GRAPHIC	g342209pc001d.jpg	GRAPHIC	1203
	Complete submission text file	0001193125-22-104314.txt		94154

Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037

Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775

Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40192 | Film No.: 22824922
SIC: 2834 Pharmaceutical Preparations